Theriva Biologics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.50
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-5.25
|
-6.81
|
-1.56
|
-29.73%
|
|
2024-06-30
|
-0.28
|
-10.75
|
-10.47
|
-3739.29%
|
|
2024-03-31
|
-0.34
|
-0.30
|
0.04
|
11.76%
|
|
2023-12-31
|
-0.41
|
-0.34
|
0.07
|
17.07%
|
|
2023-09-30
|
-0.37
|
-0.19
|
0.18
|
48.65%
|
|
2023-06-30
|
-0.36
|
-0.34
|
0.02
|
5.56%
|
|
2023-03-31
|
-0.32
|
-0.30
|
0.02
|
6.25%
|
|
2022-12-31
|
-0.33
|
-0.33
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-17.86
|
|
2023-12-31
|
-1.17
|
|
2022-12-31
|
-1.27
|
|
2021-12-31
|
-2.10
|
|
2020-12-31
|
-6.10
|
|
2019-12-31
|
-9.30
|
|
2018-12-31
|
-30.00
|
|
2017-12-31
|
-59.50
|
|
2016-12-31
|
-101.50
|
|
2015-12-31
|
-175.00
|
|
2014-12-31
|
-112.00
|
|
2013-12-31
|
-1529.65
|
|
2011-12-31
|
-1663.04
|
|
2009-12-31
|
-1541.11
|
|
2008-12-31
|
-701.51
|
|
2007-12-31
|
-8021.15
|
|
2006-12-31
|
-7947.58
|
|
2005-12-31
|
-555.86
|
|
2004-12-31
|
-5926173.90
|
|
1996-12-31
|
-199.50
|